Bersot TP, Russell SJ, Thatcher SR, Pomernacki NK, Mahley RW, Weisgraber KH, Innerarity TL, Fox CS (1993) A unique haplotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder. J. Lipid Res. 34:1149–1154.

Chiesa G, Johnson DF, Yao Z, Innerarity TL, Mahley RW, Young SG, Hammer RH, Hobbs HH (1993) Expression of human apolipoprotein B100 in transgenic mice. Editing of human apolipoprotein B100 mRNA. J. Biol. Chem. 268:23747–23750.

de Silva HV, Lauer SJ, Mahley RW, Weisgraber KH, Taylor JM (1993) Apolipoproteins E and C-III have opposing roles in the clearance of lipoprotein remnants in transgenic mice. Biochem. Soc. Trans. 21:483–487.

Dejager S, Mietus-Snyder M, Friera A, Pitas RE (1993) Dominant negative mutations of the scavenger receptor. Native receptor inactivation by expression of truncated variants. J. Clin. Invest. 92:894–902.

Dejager S, Mietus-Snyder M, Pitas RE (1993) Oxidized low density lipoproteins bind to the scavenger receptor expressed by rabbit smooth muscle cells and macrophages. Arterioscler. Thromb. 13:371–378.

Edwards WL, Bush SF, Mattingly TW, Weisgraber KH (1993) Raman spectroscopic study of boundary lipid in 1,2-dipalmitoylphosphatidylcholine/apolipoprotein A–I recombinants. Spectrochim. Acta 49A:2027–2038.

Fazio S (1993) Recent insights into the pathogenesis of type III hyperlipoproteinemia. Trends Cardiovasc. Med. 3:191–196.

Fazio S, Horie Y, Weisgraber KH, Havekes LM, Rall SC Jr (1993) Preferential association of apolipoprotein E Leiden with very low density lipoproteins of human plasma. J. Lipid Res. 34:447–453.

Fazio S, Lee Y-L, Ji Z-S, Rall SC Jr (1993) Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. J. Clin. Invest. 92:1497–1503.

Fox JEB, Lipfert L, Clark EA, Reynolds CC, Austin CD, Brugge JS (1993) On the role of the platelet membrane skeleton in mediating signal transduction. Association of GP IIb-IIIa, pp60^c–src, pp62^c-yes, and the p21^ras GTPase-activating protein with the membrane skeleton. J. Biol. Chem. 268:25973–25984.

Fox JEB, Taylor RG, Taffarel M, Boyles JK, Goll DE (1993) Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa. J. Cell Biol. 120:1501–1507.

Ji Z-S, Brecht WJ, Miranda RD, Hussain MM, Innerarity TL, Mahley RW (1993) Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268:10160–10167.

Johnson DF, Poksay KS, Innerarity TL (1993) The mechanism for apo-B mRNA editing is deamination. Biochem. Biophys. Res. Commun. 195:1204–1210.

Levy-Wilson B, Brooks AR (1993) Three liver-enriched transcription factors: HNF-1, C/EBP, and protein II are required to enhance transcription of the human apolipoprotein B gene. In: Drugs Affecting Lipid Metabolism (Catapano AL, Gotto AM Jr, Smith LC, Paoletti R, eds) Kluwer Academic Publishers, Dordrecht, The Netherlands, pp 29–44.

Linton MF, Farese RV Jr, Chiesa G, Grass DS, Chin P, Hammer RE, Hobbs HH, Young SG (1993) Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J. Clin. Invest. 92:3029–3037.

Linton MF, Farese RV Jr, Young SG (1993) Familial hypobetalipoproteinemia. J. Lipid Res. 34:521–541.

Lund-Katz S, Weisgraber KH, Mahley RW, Phillips MC (1993) Conformation of apolipoprotein E in lipoproteins. J. Biol. Chem. 268:23008–23015.

Parise LV, Steiner B, Nannizzi L, Criss AB, Phillips DR (1993) Evidence for novel binding sites on the platelet glycoprotein IIb and IIIa subunits and immobilized fibrinogen. Biochem. J. 289:445–451.

Paulweber B, Sandhofer F, Levy-Wilson B (1993) The mechanism by which the human apolipoprotein B gene reducer operates involves blocking of transcriptional activation by hepatocyte nuclear factor 3. Mol. Cell. Biol. 13:1534–1546.

Rall SC Jr, Horie Y, Fazio S (1993) The apolipoprotein E Cys-142 mutant: Role in dominant inheritance of type III hyperlipoproteinemia and expression in transgenic mice. In: Human Apolipoprotein Mutants III. Diagnosis and Treatment (Sirtori CR, Franceschini G, Brewer BH Jr, eds) Springer-Verlag, Berlin, pp 113–120.

Schmidt EB, Illingworth DR, Bacon S, Mahley RW, Weisgraber KH (1993) Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100. Atherosclerosis 98:213–217.

Schmidt EB, Illingworth DR, Bacon S, Russell SJ, Thatcher SR, Mahley RW, Weisgraber KH (1993) Hypolipidemic effects of nicotinic acid in patients with familial defective apolipoprotein B-100. Metabolism 42:137–139.

Simonet WS, Bucay N, Lauer SJ, Taylor JM (1993) A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268:8221–8229.

Snyder SM, Terdiman JF, Caan B, Feingold KR, Hubl ST, Smith RS, Young SG (1993) Relationship of apolipoprotein E phenotypes to hypocholesterolemia. Am. J. Med. 95:480–488.

Strittmatter WJ, Weisgraber KH, Huang DY, Dong L-M, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid b peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:8098–8102.

Thomas DL, Mahley RW, Badur S, Palaoglu KE, Quinn TC (1993) Epidemiology of hepatitis E virus infection in Turkey. Lancet 341:1561–1562.

Wardell MR, Wilson C, Agard DA, Mahley RW, Weisgraber KH (1993) Crystal structures of the common apolipoprotein E variants: Insights into functional mechanisms. In: Human Apolipoprotein Mutants III. Diagnosis and Treatment (Sirtori CR, Franceschini G, Brewer BH Jr, eds) Springer-Verlag, Berlin, pp 81–96.

Westerlund JA, Weisgraber KH (1993) Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J. Biol. Chem. 268:15745–15750.

Yao Z, Lauer SJ, Sanan DA, Fazio S (1993) ApoA-IV is secreted on discrete HDL particles by the rat hepatoma cell line McA-RH7777 transfected with apoA-IV cDNA. Arterioscler. Thromb. 13:1476–1486.

Young SG, Pullinger CR, Zysow BR, Hofmann-Radvani H, Linton MF, Farese RV Jr, Terdiman JF, Snyder SM, Grundy SM, Vega GL, Malloy MJ, Kane JP (1993) Four new mutations in the apolipoprotein B gene causing hypobetalipoproteinemia, including two different frameshift mutations that yield truncated apolipoprotein B proteins of identical length. J. Lipid Res. 34:501–507.

TOP